大参林 (603233)
DaShenLin Pharmaceutical Group Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 113884.79
- Circulating A-Shares(W): 113884.79
- Earnings Per Share(RMB): 0.9500
- Net Assets Per Share(RMB): 6.1815
- Operating Revenue(W RMB): 2006824.58
- Total Profit(W RMB): 152215.34
- **Net Profit Attributable to Parent(W RMB) **: 108099.63
- Net Profit Growth Rate(%): 25.97
- Weighted Return on Equity(%): 14.8500
- Operating Cash Flow Per Share(RMB): 3.2750
- Undistributed Profit Per Share(RMB): 3.6713
- Capital Reserve Per Share(RMB): 1.1200
2. Main Business
The main business covers:
- Chain retail business of pharmaceuticals, traditional Chinese medicine decoction pieces, ginseng and velvet tonics, health products, medical devices, personal care products, household goods, etc.
3. Company Basic Information
- Company Name: Dashenlin Pharmaceutical Group Co., Ltd.
- Listing Date: 2017-07-31
- Industry: Retail Industry
- Address: No. 410, No. 410-1, Longxi Avenue, Liwan District, Guangzhou City, Guangdong Province
- Website: https://www.dslyy.com/
- Company Profile: Dashenlin Pharmaceutical Group Co., Ltd. is a joint stock company legally transformed as a whole from Guangdong Dashenlin Chain Pharmacy Co., Ltd. Based on the audit report "Tianjian Audit (2013) No. 2-195" issued by Tianjian Certified Public Accountants (Special General Partnership), the net assets of RMB 271,293,355.29 as of March 31, 2013 were converted into 200 million shares at a ratio of 1:0.73720936, with the balance of RMB 71,293,355.29 recorded as capital reserve. All assets, liabilities, and equity of Dashenlin Limited were assumed by the joint stock company. On July 16, 2013, Tianjian Certified Public Accountants (Special General Partnership) issued the "Tianjian Verification (2013) No. 2-12" Capital Verification Report, reviewing the capital contributions of the promoters during the overall transformation of the limited company into a joint stock company. On August 9, 2013, the Guangdong Provincial Administration for Industry and Commerce issued the Business License to the company.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Hong Kong Securities Clearing Company Ltd. | Northbound Funds | 8494.29 | 7.46 |
| 2 | Essence Securities Pharmaceutical Health Theme Stock Initiation Securities Investment Fund Class A | Fund | 334.86 | 0.29 |
| 3 | Xingquan Organic Growth Flexible Allocation Mixed Securities Investment Fund | Fund | 131.65 | 0.12 |
| 4 | Zhongou Large Cap Value Mixed Securities Investment Fund Class A | Fund | 32.40 | 0.03 |
| 5 | Zhongou Qihe Flexible Allocation Mixed Securities Investment Fund Class A | Fund | 26.97 | 0.02 |
| 6 | Xingzheng Global Xingyu Mixed Securities Investment Fund Class A | Fund | 18.00 | 0.02 |
| 7 | Dacheng CSI 1000 Index Enhanced Initiation Securities Investment Fund Class A | Fund | 4.95 | 0.00 |
5. Concept Sectors
- Convertible Bonds
- DeepSeek
- Margin Trading & Securities Lending
- High-Performance Stocks
- Free Cash Flow
- SSE 380
- Small Cap Value
- SZSE Value
- Guoxin Value
Remarks
- Data update date: 2025-11-02
- Data source: Public Market Information